To explore the effect of each AKT isoform in ovarian cancer, we analyzed the correlation between in vivo AKT1/AKT2/AKT3 levels and patients' probability of progression-free survival, based on data from a clinical study of patients suffering from ovarian cancer (http://kmplot.com/analysis/index.php?p=service&cancer=ovar). The gene discussed is AKT3; the disease is ovarian carcinoma.